Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
33.68
+0.11 (0.33%)
At close: Jan 12, 2026, 4:00 PM EST
33.68
0.00 (0.00%)
After-hours: Jan 12, 2026, 7:00 PM EST
Smith & Nephew Employees
Smith & Nephew had 18,060 employees as of December 31, 2024. The number of employees decreased by 1,021 or -5.35% compared to the previous year.
Employees
18,060
Change (1Y)
-1,021
Growth (1Y)
-5.35%
Revenue / Employee
$329,125
Profits / Employee
$27,187
Market Cap
14.35B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18,060 | -1,021 | -5.35% |
| Dec 31, 2023 | 19,081 | -13 | -0.07% |
| Dec 31, 2022 | 19,094 | 118 | 0.62% |
| Dec 31, 2021 | 18,976 | 395 | 2.13% |
| Dec 31, 2020 | 18,581 | 551 | 3.06% |
| Dec 31, 2019 | 18,030 | 1,349 | 8.09% |
| Dec 31, 2018 | 16,681 | 348 | 2.13% |
| Dec 31, 2017 | 16,333 | 749 | 4.81% |
| Dec 31, 2016 | 15,584 | 898 | 6.11% |
| Dec 31, 2015 | 14,686 | 1,218 | 9.04% |
| Dec 31, 2014 | 13,468 | 2,432 | 22.04% |
| Dec 31, 2013 | 11,036 | 559 | 5.34% |
| Dec 31, 2012 | 10,477 | -266 | -2.48% |
| Dec 31, 2011 | 10,743 | 571 | 5.61% |
| Dec 31, 2010 | 10,172 | 408 | 4.18% |
| Dec 31, 2009 | 9,764 | 7 | 0.07% |
| Dec 31, 2008 | 9,757 | 567 | 6.17% |
| Dec 31, 2007 | 9,190 | 360 | 4.08% |
| Dec 31, 2006 | 8,830 | 212 | 2.46% |
| Dec 31, 2005 | 8,618 | 752 | 9.56% |
| Dec 31, 2004 | 7,866 | 415 | 5.57% |
| Feb 16, 2003 | 7,451 | -55 | -0.73% |
| Dec 31, 2002 | 7,506 | -420 | -5.30% |
| Dec 31, 2001 | 7,926 | -2,509 | -24.04% |
| Dec 31, 2000 | 10,435 | -778 | -6.94% |
| Dec 31, 1999 | 11,213 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SNN News
- 7 hours ago - UK's Smith & Nephew to buy Integrity Orthopaedics for up to $450 million - Reuters
- 4 days ago - Smith & Nephew: Improving And Undervalued, But Mind The Knees - Seeking Alpha
- 4 weeks ago - Smith & Nephew plc (SNN) Analyst/Investor Day Transcript - Seeking Alpha
- 5 weeks ago - Smith & Nephew boosts 2025 cashflow forecast and unveils medium-term targets - Reuters
- 2 months ago - Smith & Nephew plc (SNN) Q3 2025 Sales Call Transcript - Seeking Alpha
- 2 months ago - Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release - Seeking Alpha
- 2 months ago - Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT - GlobeNewsWire
- 2 months ago - UFC® and Smith+Nephew announce multi-year extension of partnership - GlobeNewsWire